Literature DB >> 28253939

Estimating gonorrhoea prevalence in young heterosexual men and women attending community-based sexual health services to inform decisions on gonorrhoea testing.

K Town1, M Furegato1, N Field1, G Hughes1.   

Abstract

In England, dual tests detecting chlamydia and gonorrhoea are used in specialist and community-based sexual health services (SHSs). Test performance is poor when prevalence is low, therefore UK national guidelines recommend against opportunistic gonorrhoea screening unless there is a clear local public health need. While surveillance data on gonorrhoea prevalence is comprehensive in specialist SHSs, it is sparse in community SHSs. We aimed to estimate gonorrhoea prevalence in heterosexual men and women aged 15-24 attending community SHSs to inform testing care pathways. We used linear and quadratic regression to model the relationship between prevalence in community and specialist SHSs in local authorities (LAs) with available surveillance data. We applied best-fitting models to predict prevalence in community SHSs in remaining LAs. Data from community SHSs were available for 102/326 LAs. There was a weak positive association between gonorrhoea prevalence in community and specialist SHSs in corresponding LAs within (R 2 = 0·13, P = 0·058) and outside (R 2 = 0·07, P = 0·02) London. Applying best-fitting models, we estimated a median gonorrhoea prevalence of 0·5% (mean 0·6%; range 0·2%-2·7%) in heterosexuals attending community SHSs. Despite some unexplained variation, our analyses suggest gonorrhoea prevalence in young heterosexuals attending community SHSs is below 1% in most English LAs. Our findings re-inforce the current national guidelines that recommend care pathways for gonorrhoea testing in community SHSs include confirmatory testing to reduce the risk of misdiagnosis and inappropriate management.

Entities:  

Keywords:  zzm321990 Neisseria gonorrhoeaezzm321990 ; England; community; heterosexuals; prevalence

Mesh:

Year:  2017        PMID: 28253939      PMCID: PMC9203309          DOI: 10.1017/S0950268817000024

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  7 in total

1.  Gonorrhoea notifications and nucleic acid amplification testing in a very low-prevalence Australian female population.

Authors:  Eric P F Chow; Glenda Fehler; Tim R H Read; Sepehr N Tabrizi; Jane S Hocking; Ian Denham; Catriona S Bradshaw; Marcus Y Chen; Christopher K Fairley
Journal:  Med J Aust       Date:  2015-04-06       Impact factor: 7.738

2.  Access of non-specialist sexual health services by men who have sex with men: do they differ from those attending specialist services?

Authors:  Helen Mebrahtu; Martina Furegato; Bersabeh Sile; John Were; Hamish Mohammed; Gwenda Hughes
Journal:  Sex Transm Infect       Date:  2016-11-25       Impact factor: 3.519

3.  Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013.

Authors:  E J Savage; H Mohammed; G Leong; S Duffell; G Hughes
Journal:  Euro Surveill       Date:  2014-12-04

4.  Confirmatory assays are essential when using molecular testing for Neisseria gonorrhoeae in low-prevalence settings: insights from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Authors:  Nigel Field; Soazig Clifton; Sarah Alexander; Catherine A Ison; Gwenda Hughes; Simon Beddows; Clare Tanton; Kate Soldan; Filomeno Coelho da Silva; Catherine H Mercer; Kaye Wellings; Anne M Johnson; Pam Sonnenberg
Journal:  Sex Transm Infect       Date:  2014-12-15       Impact factor: 3.519

5.  Comparison of patients diagnosed with gonorrhoea through community screening with those self-presenting to the genitourinary medicine clinic.

Authors:  Penny A Cook; John Evans-Jones; Harry Mallinson; Martyn Wood; Fath Alloba; Kathy Jones; Sara Strodtbeck; Layla Hanna-Bashara
Journal:  BMJ Open       Date:  2014-03-14       Impact factor: 2.692

6.  Screening for gonorrhoea using samples collected through the English national chlamydia screening programme and risk of false positives: a national survey of local authorities.

Authors:  Nigel Field; Iain Kennedy; Kate Folkard; Stephen Duffell; Katy Town; Catherine A Ison; Gwenda Hughes
Journal:  BMJ Open       Date:  2014-10-16       Impact factor: 2.692

7.  Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Authors:  Pam Sonnenberg; Soazig Clifton; Simon Beddows; Nigel Field; Kate Soldan; Clare Tanton; Catherine H Mercer; Filomeno Coelho da Silva; Sarah Alexander; Andrew J Copas; Andrew Phelps; Bob Erens; Philip Prah; Wendy Macdowall; Kaye Wellings; Catherine A Ison; Anne M Johnson
Journal:  Lancet       Date:  2013-11-26       Impact factor: 79.321

  7 in total
  1 in total

1.  Spatial clusters of gonorrhoea in England with particular reference to the outcome of partner notification: 2012 and 2013.

Authors:  Allen O'Brien; Ellie Sherrard-Smith; Bersabeh Sile; Charlotte Watts; Ian Simms
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.